Dergiler / Marmara Medical Journal / 2023 / Cilt: 36 Sayı: 2

Increased D-dimer is associated with disease progression and increased mortality in Turkish COVID-19 patients

Sayfa
175–181
Yayın Tarihi
2023-05-31
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

D-dimer levels of 3.25 mg/L and above, strongly determine the risk of increased mortality in the Turkish Caucasian ethnic group.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Coagulopathy is thought to play an important role in the development of severe COVID-19.
📊
Temel Bulgular & Veri:However, ethnicity has significant implications for thrombotic risk.
💡
Sonuç & Katkı:D-dimer levels of 3.25 mg/L and above, strongly determine the risk of increased mortality in the Turkish Caucasian ethnic group.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:COVID-19 · D-dimer · Mortality

Abstract

Objective: Coagulopathy is thought to play an important role in the development of severe COVID-19. High D-dimer levels have been reported in Chinese cohort studies. However, ethnicity has significant implications for thrombotic risk. Our aim in this study is to determine the effect of D-dimer measurements on disease prognosis and mortality in Turkish patients with COVID-19. Patients and Methods: The study was designed retrospectively. Patients over the age of 18 who were admitted to our hospital were included in the study. Results: The study included 226 patients. According to the World Health Organization staging, 75(33.2%) patients, according to the staging of Siddiqi et al., 67 (29.7%) patients progressed. In the ROC analysis performed to predict mortality, AUC value for D-dimer was found to be 82.25% (95%CI 74.8%-89.71%). When the cut-off value for D-dimer was accepted as ≥3.25mg/L, specificity was 94.15%, correctly classified rate 88.5%, positive likelihood ratio as (LR):5.69, negative LR:0.71. Conclusion: As a result, similar to the Chinese cohorts, elevated D-dimer measurements increase disease progression and mortality in Turkish patients with COVID-19. D-dimer levels of 3.25 mg/L and above, strongly determine the risk of increased mortality in the Turkish Caucasian ethnic group.

🔖

Bu Makaleye Atıf Yap

MERCANCI, Z., ILGIN, C., YILDIZELI, S. O., KOCAKAYA, D., BALCAN, B., SENGEL, B. E., KARAKURT, S., ERYUKSEL, E. (2023). Increased D-dimer is associated with disease progression and increased mortality in Turkish COVID-19 patients. Marmara Medical Journal, Cilt: 36 Sayı: 2, 175–181. https://ajindex.com/articles/941421

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (10)

  1. World Health Organization, Director-General’s remarks at the media briefing, April 14th 2020 Available at: https:// www.who.int/director-general/speeches/detail/who-directorgeneral- s-remarks-at-the-media-briefing-on-2019-ncov-on- 11-february-2020. Accessed 11.02.2020 [2] Connors JM, Levy JH. Thromboinflammation and the hypercoagulability of COVID-19. J Thromb Haemost 2020
  2. doi: 10.1111/jth.14849. [3] Magro C, Mulvey JJ, Berlin D, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Transl Res 2020
  3. doi: 10.1016/j.trsl.2020.04.007. [4] Fox SE, Akmatbekov A, Harbert JL, Li G, Quincy Brown J, Vander Heide RS. Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans. Lancet Respir Med 2020
  4. doi: 10.1016/s2213-2600(20)30243-5. [5] Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. N Engl J Med 2020
  5. doi: 10.1056/ NEJMoa2015432. [6] Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020
  6. doi: 10.1016/s0140-6736(20)30566-3. [7] Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 2020
  7. doi: 10.1111/jth.14817. [8] Liao S, Woulfe T, Hyder S, Merriman E, Simpson D, Chunilal S. Incidence of venous thromboembolism in different ethnic groups: a regional direct comparison study. J Thromb Haemost 2014
  8. doi: 10.1111/jth.12464. [9] Fogarty H, Townsend L, Ni Cheallaigh C, et al. COVID19 coagulopathy in Caucasian patients. Br J Haematol 2020
  9. doi: 10.1111/bjh.16749. [10] Republic of Turkey, Ministry of Health Available at: https:// covid19.saglik.gov.tr/TR-66301/covid-19 – rehberi.html. Accessed on 12.02.2020 [11] Schünemann HJ, Khabsa J, Solo K, et al. Ventilation Techniques and risk for transmission of coronavirus disease, including COVID-19: A living systematic review of multiple streams of evidence. Ann Intern Med 2020
  10. doi: 10.7326/m20-2306. [12] Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med 2017